Participants 92 129 11
, in 14 outpatient autistic children.
Participants 131 334 11
Fourteen children (12 infantile autism full syndrome present, 2 atypical pervasive developmental disorder) between 5 and 13 years of age participated in a double-blind placebo-controlled cross-over trial
